Quantitative Structure Activity Relationship (QSAR)
QSAR is the mathematical heart of Computer Aided Drug Design. It converts qualitative chemical intuition (‘this chlorine group makes the drug stronger’) into a precise mathematical equation that can numerically predict the potency of a molecule that has never been synthesized. This unit covers the history of QSAR, the critical physicochemical parameters (hydrophobic, electronic, and steric), and the landmark analytical approaches—Hansch Analysis, Free-Wilson Analysis, and the visually stunning 3D-QSAR methods CoMFA and CoMSIA.
Syllabus & Topics
- 1SAR versus QSAR: Structure-Activity Relationship (SAR): A purely qualitative, verbal description of how changing a chemical group affects biological activity. ‘Adding a methyl group at position 3 increases potency.’ QSAR: Converts this into a mathematical equation: log(1/C) = a·logP + b·σ + c·Es + d. It uses computed physicochemical descriptors to quantify the exact mathematical contribution of each chemical modification to the overall biological potency, allowing numerical prediction.
- 2History and Development of QSAR: Crum-Brown & Fraser (1868): Proposed that biological activity is a function of chemical constitution (Φ = f(C)). Richet, Meyer, Overton (1890s): Discovered the correlation between lipophilicity (fat-solubility) and anesthetic potency. Hammett (1937): Introduced the σ (sigma) substituent constant to quantify electronic effects. Hansch & Fujita (1964): Merged lipophilic, electronic, and steric parameters into the revolutionary Hansch equation—the birth of modern QSAR.
- 3Physicochemical Parameters: Partition Coefficient (log P): Measures the hydrophobicity/lipophilicity of a molecule. Determined experimentally via the Shake-Flask method (partitioning the drug between octanol and water). The parameter π (pi) measures the hydrophobic contribution of individual substituent groups. Hammett’s Substituent Constant (σ): Quantifies the electron-withdrawing or electron-donating power of a chemical substituent relative to hydrogen. A positive σ means the group is electron-withdrawing (e.g., -NO₂). Taft’s Steric Constant (Es): Quantifies the physical ‘bulkiness’ (steric hindrance) of a substituent. Based on the rate of acid hydrolysis of substituted esters relative to a methyl ester.
- 4Hansch Analysis: The Hansch equation is the most fundamental equation in all of QSAR. General Form: log(1/C) = a·logP – b·(logP)² + c·σ + d·Es + constant. It performs a Multiple Linear Regression (MLR) to mathematically determine the coefficients (a, b, c, d) that best fit experimental biological data. The parabolic logP term accounts for the fact that a drug must be optimally lipophilic—too hydrophilic and it can’t cross the cell membrane; too lipophilic and it gets trapped in fat tissue and never reaches the target.
- 5Free-Wilson Analysis: An alternative approach that doesn’t require calculating any physicochemical parameters. Logic: It statistically assigns a pure numerical ‘activity contribution value’ (aᵢ) to each individual structural feature/substituent present on the molecule. BA = μ + Σaᵢ, where BA is the Biological Activity and μ is the average activity of the parent unsubstituted compound. Advantage: Works perfectly for congeneric series where steric, electronic, and lipophilic effects are impossible to mathematically disentangle. Limitation: Cannot predict activity of groups with structural features not present in the original training dataset.
- 63D-QSAR: CoMFA and CoMSIA: A massive technological leap beyond traditional 2D QSAR. CoMFA (Comparative Molecular Field Analysis): Aligns all drug molecules in 3D space. Places them inside a virtual 3D grid. A probe atom systematically moves to every grid point, calculating the steric and electrostatic interaction energy at each location. Generates stunning 3D contour maps showing exactly WHERE bulky groups enhance/diminish activity and WHERE positive/negative charges are needed. CoMSIA (Comparative Molecular Similarity Indices Analysis): Extends CoMFA by adding hydrophobic, hydrogen-bond donor, and hydrogen-bond acceptor fields, providing a more comprehensive 3D picture.
Learning Objectives
Exam Prep Questions
Q1. Why does the Hansch equation contain a (logP)² term instead of only logP?
Drug activity does not increase indefinitely with lipophilicity. A molecule must be sufficiently lipophilic to cross biological membranes, but if it becomes too lipophilic, it may accumulate in fatty tissues and fail to reach its target in the bloodstream or tissues.
This creates a parabolic relationship between lipophilicity and biological activity, where activity increases with lipophilicity up to an optimal point and then decreases beyond it. The (logP)² term in the Hansch equation mathematically represents this curved relationship, allowing researchers to estimate the optimal lipophilicity (logP₀) at which drug activity is maximized.
Q2. What is the fundamental difference between Hansch Analysis and Free-Wilson Analysis?
Hansch Analysis is based on the relationship between biological activity and physicochemical properties such as lipophilicity (logP), electronic effects (σ), and steric parameters (Es). It generates a mathematical model that can help predict the activity of new compounds using these calculated properties.
Free-Wilson Analysis, in contrast, focuses on the contribution of specific substituent groups present in the molecules tested. It assigns statistical activity values to structural fragments based on experimental data. However, this method can only evaluate substituents already included in the dataset, making it less useful for predicting completely new structures.
In summary, Hansch analysis emphasizes physicochemical properties, while Free-Wilson analysis emphasizes structural fragments.
Q3. Why is CoMFA considered revolutionary compared to traditional 2D QSAR methods?
Traditional QSAR methods, such as Hansch or Free-Wilson analysis, simplify molecules into two-dimensional numerical descriptors, such as lipophilicity or electronic parameters. While useful, these approaches do not capture the three-dimensional arrangement of atoms that strongly influences how a drug interacts with its biological target.
Comparative Molecular Field Analysis (CoMFA) introduced a major advancement by analyzing the three-dimensional steric and electrostatic fields surrounding molecules. In CoMFA, molecules are aligned in a virtual 3D grid, and the interactions at different spatial points are evaluated to identify regions where steric bulk or electrostatic properties improve or reduce biological activity.
This produces 3D contour maps that visually guide chemists in modifying molecular structures to enhance activity—an insight that cannot be obtained from traditional 2D QSAR models.